Great Valley Advisor Group »

Eyepoint Pharmaceuticals shares owned by Great Valley Advisor Group

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Great Valley Advisor Group from 13F filings

Historical chart of Great Valley Advisor Group investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Great Valley Advisor Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Great Valley Advisor Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $139k 11k 12.93

More positions owned by Great Valley Advisor Group

NVIDIA Corporation (NVDA)
Spdr Series Trust State Street Spd (SPYM)
Wisdomtree Tr Us Largecap Divd (DLN)
American Centy Etf Tr Us Quality Grow (QGRO)
Apple (AAPL)
Pimco Etf Tr Active Bd Etf (BOND)
Invesco Exch Traded Fd Tr Ii S&p Intl Momnt (IDMO)
World Gold Tr Spdr Gld Minis (GLDM)
Capital Grp Fixed Incm Etf T Us Multi-sector (CGMS)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Amazon (AMZN)
Victory Portfolios Ii Shares Free Cash (VFLO)
J P Morgan Exchange Traded F Intrnl Res Eqt (JIRE)
Microsoft Corporation (MSFT)
Legg Mason Etf Invt Franklin Intl Lw (LVHI)

View all positions for Great Valley Advisor Group

Top funds holding Eyepoint Pharmaceuticals

Suvretta Capital Management
Cormorant Asset Management
BlackRock
Federated Investors
Franklin Resources
Vanguard Group
Adage Capital Partners GP
Henderson Group
Vanguard Capital Management
Paradigm Biocapital Advisors
Commodore Capital
Citadel Advisors
Geode Capital Management
State Street Corporation
Standard Life Aberdeen

View all funds holding Eyepoint Pharmaceuticals